RMDHealthcareLarge-Cap

RESMED INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for RESMED INC (RMD), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are RMD insiders buying or selling?

RESMED INC insiders reported 0 open-market buys ($0) and 430 sells ($316.4M) across 430 Form 4 filings — a net selling position of $316.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 11, 2026)

Total Form 4 filings
430
SEC EDGAR
Insider filers
20
Insider buys (0)
$0
Insider sells (430)
$316.4M

Insider sentiment

Net selling

Net insider flow of $316.4M in net selling.

Recent RMD insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 11, 2026Michael J. FarrellChairman and CEOSale5.0K$205.69$1.0M
Aug 6, 2026FARRELL PETER CDirectorSale8.0K$225.00$1.8M
Jul 9, 2026Michael J. FarrellChairman and CEOSale5.0K$218.55$1.1M
Jun 9, 2026Michael J. FarrellChairman and CEOSale5.0K$193.96$968.1K
May 11, 2026Michael J. FarrellChairman and CEOSale5.0K$207.82$1.0M
Apr 9, 2026Michael J. FarrellChairman and CEOSale5.0K$225.50$1.1M
Apr 3, 2026Brett SandercockChief Financial OfficerSale1.0K$224.31$224.3K
Apr 2, 2026FARRELL PETER CDirectorSale2.0K$225.00$450.0K
Mar 11, 2026Michael J. FarrellChairman and CEOSale5.0K$251.03$1.3M
Mar 5, 2026FARRELL PETER CDirectorSale2.0K$260.22$520.4K
Feb 10, 2026Michael J. FarrellChairman and CEOSale5.0K$273.78$1.4M
Feb 6, 2026FARRELL PETER CDirectorSale2.0K$251.31$502.6K
Feb 6, 2026Michael J RiderGlobal General CounselSale50$260.00$13.0K
Feb 3, 2026Brett SandercockChief Financial OfficerSale1.0K$257.03$257.0K
Jan 9, 2026FARRELL PETER CDirectorSale2.0K$248.83$497.7K
Jan 8, 2026Michael J. FarrellChairman and CEOSale5.0K$248.46$1.2M
Jan 5, 2026Brett SandercockChief Financial OfficerSale1.0K$241.75$241.8K
Jan 5, 2026Michael J RiderGlobal General CounselSale50$241.75$12.1K
Dec 9, 2025Michael J. FarrellChairman and CEOSale5.0K$251.41$1.3M
Dec 4, 2025FARRELL PETER CDirectorSale2.0K$251.47$502.9K
Dec 2, 2025Michael J RiderGlobal General CounselSale50$244.16$12.2K
Dec 2, 2025Brett SandercockChief Financial OfficerSale1.0K$244.16$244.2K
Nov 26, 2025Witte Jan DeDirectorSale2.1K$255.00$524.0K
Nov 13, 2025FARRELL PETER CDirectorSale2.0K$252.05$504.1K
Nov 13, 2025Witte Jan DeDirectorSale487$250.25$121.9K

Showing the 25 most recent of 430 Form 4 filings for RESMED INC.

Most active RMD insiders

  • Brett Sandercock88 filings
  • Michael J. Farrell67 filings
  • David Pendarvis65 filings
  • Robert Andrew Douglas52 filings
  • James Hollingshead49 filings

Ask anything about RMD insider activity

Use Trabud's AI agent to query RESMED INC's Form 4 history in plain English — "Show me RMD CEO purchases this year" or compare it against any other ticker.

Open the AI agent

RMD insider trading FAQ

Are RESMED INC insiders buying or selling?

Across 430 SEC Form 4 filings, RESMED INC (RMD) insiders reported 0 open-market purchases totaling $0 and 430 sales totaling $316.4M. That is a net selling position of $316.4M.

How many insiders trade RMD stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for RESMED INC. The most recent filing was accepted on Aug 11, 2026.

Where does Trabud get RMD insider trading data?

All RMD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content